DOCSLIB.ORG

CD Antigen Expression (Myeloid & Lymphoid)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CD Antigen Expression (Myeloid & Lymphoid) CD Antigen Expression Immunological Excellence MYELOID Pluripotent LYMPHOID Stem Cell CD90* CD123 CFU-GEMM Myeloid CD110* CD135* Lymphoid Stem Cell CD117 CD243 Markers expressed CD10 CD117 Stem Cell CD34 CD124 by the majority of CD33 CD112* CD133* CD227* CD38 CD127 CD34 CD117 CD173* CD228 CD90* CD228 Leucocytes CD110* CD123 CD174* CD11a CD55 CD132 CD111* CDw131 CD176 CD18 CD58 CD148 CD29 CD59 CD156b CD44 CD62L CDw217 Pro-B Cell Subcortical Thymocyte CD45 CD82 CD220 CD19 CD79a CD2 CD8 CD46 CD100 CD221 CD22 CD79b CD4 CD38 CD47 CD118 CD222 CD24 CD124 CD5 CD200 CD47R CD120a CD224 CD34 CD127 CD7 CD50 CD120b CD225 BFU-E CFU-GM CD38 CD179a CD53 CD126 CD230 CD33 CD72 CD179b CD54 CD130 CD232 CD34 Myelomonocytic CDw123 Stem Cell Cortical Thymocyte CDw131 CD1a CD4 CD52 CD13 CD111 CD116 Pre-Pre-B Cell CD1b CD5 CD165 CD33 CD112 CDw123 CD10 CD72 THYMUS CD1c CD7 CD200 CD34 CD115 CDw131 CD19 CD79a CD2 CD8 CD20 CD79b CD3 CD38 CD22 CD124 CD24 CD179a CD34 CD179b CFU-E CFU-Meg CFU-M CFU-G CFU-Eo CFU-Bas Pre-B Cell Medullary Medullary CD36 CD34 CD13 CD115 CD13 CD112 CD13 CD34 CD9 CD72 CDw123 CDw123 CD15 CD116 CD15 CD116 CD33 CDw123 CD10 CD74 Thymocyte Thymocyte CDw131 CD110 CD33 CDw123 CD33 CDw123 CD34 CD19 CD79a CD4+ CD8+ CD175s CD111 CDw131 CD111 CDw131 CD116 CD20 CD79b CD112 CDw123 CD22 CD124 CDw131 CD24 CD179a CD38 CD179b BONE MARROW CD40 CD2 CD7 CD150 (CD49f) CD121a Early B Cell CD3 CD27 CD155 CD52 CD127 Reticulocyte Megakaryocyte Promonocyte Myelocyte Myelocyte Myelocyte CD5 CD28 CD48 CD69 CD165 CD41 (CD51) CD13 CD112 CD13 CD114 CD11b CD35 (CD15*) CD19 CD40 CD6 (CD38) (CD49d) CD99 CD168* CD42a CD61 CD14 CD115 (CD15*) CD116 CD13 CD116 CD33 CD20 CD72 CD200 CD42b CD110 (CD15*) CD116 (CD33) CDw123 (CD15*) CD114 CDw123 CD22 CD74 CD42c CDw123 CD33 CDw123 CD111 CDw131 CD32 CDw131 CD114 CD24 CD79a CD42d CDw131 CD111 CD131 CD112 CD33 CD37 CD79b CD49f CD203c (CD39) CD124 Intermediate LGL/Null Suppressor/Inducer Cytotoxic/Suppressor Erythrocyte Platelets Monocyte Neutrophil Eosinophil Basophil B Cell Cell/NK Cell T Lymphocyte T Lymphocyte CD4+ CD8+ CD45RA+ CD10 CD65s CD116 CD9 CD32 CD116 CD9 CD38 CD154 CD19 CD40 CD79a (also found in tissues) CD35 CD235b CD9 (CD51) (CD4) CD63 CD127 CD2 CD43 CD73* CD124 CD171* CD44 CD236 CDw17 CD60a CD9 CD64 CDw128 CD15s CD66a CDw123 CD11b CD35 CDw125 CD17 CD43 CDw125 CD20 CD48 CD79b CD2* CD56 CD160* CD16b CD66d CDw128 CD15 CD43 CDw131 CD25 CD114 CDw128 CD21 CD52 CD80* CD3 CD45RB* CD75s* CDw128* CD172a* CD55 CD236R CD23 CD61 CD11b CD65s CDw131 CD7* CD57 CD161 CD5 CD45RC* (CD75*) CDw137* CD184* CD59 CD238 CD31 CD84 CD11c CD68 CD142* CD17 CD89 CDw131 CD24 CD114 CD33 CDw131 CD203c CD22 CD72 (CD85) CD8* CD69 CD162R* CD24 CD92 CD157 CD24 CD74 CD99 CD6* CD48 CD94* CD147* CD195* CD147 CD239 CD36 CD92 CDw12 (CD74) CD147 CD11b CD94 CDw210 CD7 CD49d CD98 CD161 CDw197* CD173 CD240CE CD41 CD109 CD13 CD84 CD155 CD32 CD93 CD170 CD32 CD75 CD124 CD11c CD122 CD226 CD35 CD111 CD177* CD35 CD75s CDw210 CD11c* (CD49f) CD99 CD150 CDw210 CD233 CD240D CD42a (CD110) CD14 CD85 CD156a CD16 CD158a CD244 (CD27*) CD57* CD101* CD158a* CD226 CD234 CD241 CD42b CD147 CD15 CD86 CD157 CD43 CD112 CD37 CD35* CD158b CD247 CD65 CD114 CD28* CD60a* CD102 CD158b* (CD229) CD235a CD242 CD42c CD151 CDw17 CD87 CD162 CD48 CD159 CD31 CD60b CD103* CD160* CD244* CD42d CD173 (CD31) CD89 CD163 Mature B Cell CD35 CD60c CD121a CD162 CD245* CD49b CD226 CD32 CD91 CD164 (CD37) (CD70) CD122* CD164 CD247 CD49f CD33 CDw92 CD168 CD35 CD93 (CD170) CD5* CD40 CD78 CDw121b CD36 CD98 CD171 Granulocytes CD19 CD48 CD79a CD124 CD38 CD101 CD172a CD20 CD49b CD79b CD171* Helper/Inducer (CD40) CD102 CD180 CD11b CD31 CD66b (CD98) CD21 CD49c CD80* CD180* CD43 CD111 CD184 CD11c CD43 CD66c CDw101 CD22 CD49d CD84 CDw210 T Lymphocyte CD24 CD52 (CD85) CD213a1 (CD45RO) CD112 CD195 CDw12 CD45RO CD87 CD123 CD4+ (CD45RA) CD115 CD206 CD13 CD52* CD88 CD156a CD32 CD72 (CD98) CD213a2 + CD35 CD74 CD99 (CD229) CD45RO (CD45RB) CD116 CD213a1 (CD14*) (CD63) CD114 CDw197+ CD49b CD119 CD213a2 CD37 CD75* CD102 CD49e CDw121b CDw210 (CD39) CD75s* CD119 CD49f CDw123 CD226 Activated T Cell Activated Platelets Activated Neutrophil Activated Eosinophil Activated Basophil Activated B Cell CD62P CD107a + CD64 CD66+ CD23 CD64 CD66 + CD64 CD66 + CD63 CD107b CD2R CD49b CD71 CD109 CD154 CD223 CD23 CD30 CD69 (CD83) CD25 CD49e (CD83) CD134* CD166 CD25 CD38 CD70 CD86 CD26 CD49f CD87 CD146 CD178 CD26 CD60b CD71 CD30 CD69 CD96 CD152 CD183 CD28 CD166 CD80 CD38 CD70 CD108 CD153 CD212 Immunoblast Macrophage Activated LYMPH NODE CD10 CD22 (CD39) CD74 KEY Macrophage CD19 CD24 CD40 CD79a Endothelial Cells CD23 CD69 Dendritic (also found in bone marrow) CD20 CD37 CD72 CD79b * Subset expression E Erythroid CD25 CD105 CD139 CD62E CD116 CD144 CD201* Cells BFU-E Burst forming unit Eo Eosinophil CD92 CD121a CDw145 CD202b + – Erythroid precursor CD85 CD206* G Granulocyte CD93 CD124 CD146 CD213a1 CD Strong expression CD102 CD140b* CD147 CD213a2 CD180 CD207* Lymphoplasmacytoid Plasma Cell M Monocyte CD187 CD208* (CD) Weak expression CD105 CD141 CD152 CD38 CD126 CD11c CD32 CD68 CD101 CD169* CD205 CD209* Cell CD19 CD79a Meg Megakaryocyte CD106 CD142* CD157 CD20 CD79b CD79a CD138 CFU Colony forming unit CD109 CD143* CD166 CD14 CD36 CD71 CD119 CD170* NK Natural Killer CD16 CD45RO CD74 CD121b CD204 CD38 CFU-GM Colony forming unit CD26 CD45RB CD87 CD155 CD206 Granulocyte-monocyte LGL Large granular TISSUE BLOOD CD31 CD63 CD88 CD156a CDw210 common precursor lymphocyte Cluster Cluster Cluster Cluster Desig- Antigen Desig- Antigen Desig- Antigen Desig- Antigen nation Main Antigen Expression Other names Mol. Wt (kD) nation Main Antigen Expression Other names Mol. Wt (kD) nation Main Antigen Expression Other names Mol. Wt (kD) nation Main Antigen Expression Other names Mol. Wt (kD) CD1a Cortical Thymocytes (stg), B Cell subset 49,12 CD51 Platelets aV Integrin 125/25 CD112 Monocytes, neutrophils, stem cell subset PRR2/Nectin-2 64–72 CD172a Monocytes, T cell subset, stem cells SIRP alpha 110 Dendritic Cells, Langerhans Cells CD51/61 Platelets, Osteoclasts, Endothelial Cells complex CD113 Not Assigned CD173 Red cells, stem cell subset, platelets Blood group H type 2 CHO CD1b Cortical Thymocytes (mod), B Cell subset 45,12 Dendritic Cells, Langerhans Cells CD52 Leucocytes CAMPATH-1 21–28 CD114 Granulocytes, Monocytes G-CSF Receptor 95,139 CD174 Stem cell subset, epithelial cells Lewis Y CHO CD1c Cortical Thymocytes (weak), B Cell subset 43,12 CD53 Leucocytes 32-40 CD115 Monocytes, Macrophages M-CSF Receptor 150 CD175 Stem cell subset TN CHO Dendritic Cells, Langerhans Cells CD54 Endothelial Cells, Various Activated Cells ICAM-1 90 CD116 Monocytes, Neutrophils, Eosinophils GM-CSF Receptor a Chain Fibroblasts 60 CD175s Erythroblasts Sialyl-Tn CHO CD2 T Cells, NK Cells LFA-2, E-Rosette Receptor 50 CD55 Broad Decay Accelerating Factor 75 CD117 Progenitor Cells SCF-Receptor, c-kit 145 CD176 Stem cell subset Thomson-Friedrenreich antigen CHO CD2R Activated T Cells 50 CD56 NK Cells N-CAM 220/135 CD118 Broad IFN α, β Receptor 90 CD177 Neutrophil subset NB1 56–62 CD3 T Cells 16,20,25–28 CD57 NK Cells, T Cell Subset HNK-1 110 CD119 Monocytes, B Cells, Epithelial Cells IFN γ Receptor 90 CD178 Activated T cells Fas ligand 38–42 CD4 Helper-Inducer T Cells, Monocytes, Macrophages 56 CD58 Broad LFA-3 65–70 CD120a Monocytes, Granulocytes TNF Receptor, Type 1 55 CD179a Pro B cells, pre B cells V pre beta 16 CD5 T Cells, B Cell Subset 67 CD59 Broad Protectin, Homologous 18–20 CD120b Monocytes, Granulocytes TNF Receptor, Type 2 75 CD179b Pro B cells, pre B cells Lambda 5 22 Restriction Factor Activated Lymphocytes CD6 T Cells, B Cell Subset 105 CD180 B cell subset, monocytes, dendritic cells Rp105/Bgp 95 95–105 CD60a T cell subset, platelets GD3 CHO CD121a T Cells, Fibroblasts, Endothelial Cells IL-1 Receptor, Type 1 80 CD7 T Cells 40 CD183 Activated T cells, activated NK cells CXCR3 40 CD60b T cell subset, activated B cells 9-0-sialyl GD3 CHO CDw121bB Cells, Monocytes, Macrophages IL-1 Receptor, Type 2 68 CD8 Cytotoxic/Suppressor T Cells, NK Cells 32–34 CD184 T cell subset, B cells, monocytes, Denritic cells, CXCR4 45 β CD9 Platelets, Monocytes, Pre B Cells 24 CD60c T cell subset 7-0-sialyl GD3 CHO CD122 T Cell Subset, NK Cells IL-2 Receptor Chain 75 endothelial cells β α CD10 Pre B Cells, Granulocytes CALLA 100 CD61 Platelets, Megakaryocytes 3 Integrin, GPIIIa 110 CDw123 Progenitor Cells, Granulocytes IL-3 Receptor Chain 70 CD195 Monocytes, T cell subset CCR5 45 Monocytes, Megakaryocytes CD11a Leucocytes LFA-1, αL Intergrin 180 CD62E Endothelial Cells E-Selectin, ELAM-1 140 CDw197 T cell subset CCR7 45 CD124 B Cells, T Cells, Progenitor Cells IL-4/IL-13 Receptor 140 CD11b Granulocytes, Monocytes, NK Cells MAC-1, αM Intergrin, CR3 170 CD62L Lymphocytes, Monocytes, NK Cells L-Selectin, LECAM-1 150 CD200 Thymocytes, B cells, endothelium, activated T cells OX-2 45–50 CDw125 Eosinophils, Basophils IL-5 Receptor α Chain 60 CD11c Granulocytes, Monocytes, NK Cells, αX Intergrin 150 CD62P Activated Platelets, Endothelial Cells P-Selectin, LECAM-3 75–80 CD201 Endothelial cell subset Endothelial cell Protein C receptor 50 CD126 Plasma Cells, Activated B Cells IL-6 Receptor α Chain 80 (EPCR) T Cell Subset, B Cell Subset CD63 Activated Platelets, Monocytes 53 α CDw12 Granulocytes, Monocytes 90–120 CD127 Early B Cells, T Cells IL-7 Receptor Chain 65–75 CD202b Endothelial cells, stem cells Tie/Tek 150 CD64 Monocytes FcRI 75 Progenitor Cells, Monocytes CD13 Granulocytes, Monocytes Aminopeptidase N 130 CD203c Basophils, megakaryocytes NPP3 130–150 CD65 Neutrophils CDw128 Neutrophils, Monocytes,
Load more

Recommended publications
  • ENSG Gene Encodes Effector TCR Pathway Costimulation Inhibitory/Exhaustion Synapse/Adhesion Chemokines/Receptors
    ENSG Gene Encodes Effector TCR pathway Costimulation Inhibitory/exhaustion Synapse/adhesion Chemokines/receptors ENSG00000111537 IFNG IFNg x ENSG00000109471 IL2 IL-2 x ENSG00000232810 TNF TNFa x ENSG00000271503 CCL5 CCL5 x x ENSG00000139187 KLRG1 Klrg1 x ENSG00000117560 FASLG Fas ligand x ENSG00000121858 TNFSF10 TRAIL x ENSG00000134545 KLRC1 Klrc1 / NKG2A x ENSG00000213809 KLRK1 Klrk1 / NKG2D x ENSG00000188389 PDCD1 PD-1 x x ENSG00000117281 CD160 CD160 x x ENSG00000134460 IL2RA IL-2 receptor x subunit alpha ENSG00000110324 IL10RA IL-10 receptor x subunit alpha ENSG00000115604 IL18R1 IL-18 receptor 1 x ENSG00000115607 IL18RAP IL-18 receptor x accessory protein ENSG00000081985 IL12RB2 IL-12 receptor x beta 2 ENSG00000186810 CXCR3 CXCR3 x x ENSG00000005844 ITGAL CD11a x ENSG00000160255 ITGB2 CD18; Integrin x x beta-2 ENSG00000156886 ITGAD CD11d x ENSG00000140678 ITGAX; CD11c x x Integrin alpha-X ENSG00000115232 ITGA4 CD49d; Integrin x x alpha-4 ENSG00000169896 ITGAM CD11b; Integrin x x alpha-M ENSG00000138378 STAT4 Stat4 x ENSG00000115415 STAT1 Stat1 x ENSG00000170581 STAT2 Stat2 x ENSG00000126561 STAT5a Stat5a x ENSG00000162434 JAK1 Jak1 x ENSG00000100453 GZMB Granzyme B x ENSG00000145649 GZMA Granzyme A x ENSG00000180644 PRF1 Perforin 1 x ENSG00000115523 GNLY Granulysin x ENSG00000100450 GZMH Granzyme H x ENSG00000113088 GZMK Granzyme K x ENSG00000057657 PRDM1 Blimp-1 x ENSG00000073861 TBX21 T-bet x ENSG00000115738 ID2 ID2 x ENSG00000176083 ZNF683 Hobit x ENSG00000137265 IRF4 Interferon x regulatory factor 4 ENSG00000140968 IRF8 Interferon
    [Show full text]
  • Cd160 Mouse Shrna Plasmid (Locus ID 54215) – TR514223 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TR514223 Cd160 Mouse shRNA Plasmid (Locus ID 54215) Product data: Product Type: shRNA Plasmids Product Name: Cd160 Mouse shRNA Plasmid (Locus ID 54215) Locus ID: 54215 Synonyms: AU045688; By55 Vector: pRS (TR20003) Format: Retroviral plasmids Components: Cd160 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 54215). 5µg purified plasmid DNA per construct Non-effective 29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. RefSeq: BC021596, NM_001163496, NM_001163497, NM_018767 Summary: CD160 antigen: Receptor on immune cells capable to deliver stimulatory or inhibitory signals that regulate cell activation and differentiation. Exists as a GPI-anchored and as a transmembrane form, each likely initiating distinct signaling pathways via phosphoinositol 3- kinase in activated NK cells and via LCK and CD247/CD3 zeta chain in activated T cells (By similarity). Receptor for both classical and non-classical MHC class I molecules (PubMed:16177084). Receptor or ligand for TNF superfamily member TNFRSF14, participating in bidirectional cell-cell contact signaling between antigen presenting cells and lymphocytes. Upon ligation of TNFRSF14, provides stimulatory signal to NK cells enhancing IFNG production and anti-tumor immune response (PubMed:25711213). On activated CD4+ T cells, interacts with TNFRSF14 and downregulates CD28 costimulatory signaling, restricting memory and alloantigen-specific immune response (By similarity). In the context of bacterial infection, acts as a ligand for TNFRSF14 on epithelial cells, triggering the production of antimicrobial proteins and proinflammatory cytokines (PubMed:22801499).[UniProtKB/Swiss-Prot Function] shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Human NK Cells with the 2B4 Receptor Inhibits Self-Killing of the Association of MHC Class I Proteins
    The Association of MHC Class I Proteins with the 2B4 Receptor Inhibits Self-Killing of Human NK Cells This information is current as Gili Betser-Cohen, Saar Mizrahi, Moran Elboim, Osnat of September 27, 2021. Alsheich-Bartok and Ofer Mandelboim J Immunol 2010; 184:2761-2768; Prepublished online 17 February 2010; doi: 10.4049/jimmunol.0901572 http://www.jimmunol.org/content/184/6/2761 Downloaded from References This article cites 39 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/184/6/2761.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Association of MHC Class I Proteins with the 2B4 Receptor Inhibits Self-Killing of Human NK Cells Gili Betser-Cohen, Saar Mizrahi, Moran Elboim, Osnat Alsheich-Bartok, and Ofer Mandelboim The killing activity of NK cells is carried out by several activating NK receptors, which includes NKp46, NKp44, NKp30, NKp80, NKG2D, and 2B4.
    [Show full text]
  • Characterization of a Novel Mouse Model with Genetic Deletion of CD177
    Protein Cell 2015, 6(2):117–126 DOI 10.1007/s13238-014-0109-1 Protein & Cell RESEARCH ARTICLE Characterization of a novel mouse model with genetic deletion of CD177 Qing Xie1,2, Julia Klesney-Tait3, Kathy Keck3, Corey Parlet2, Nicholas Borcherding2, Ryan Kolb2, Wei Li2, & Lorraine Tygrett2, Thomas Waldschmidt2, Alicia Olivier2, Songhai Chen4, Guang-Hui Liu5,6, Xiangrui Li1 , Weizhou Zhang2& 1 College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China 2 Department of Pathology, Holden Comprehensive Cancer Center, Carver College of Medicine/University of Iowa, Iowa, IA 52242, USA 3 Department of Internal Medicine, Carver College of Medicine/University of Iowa, Iowa, IA 52242, USA 4 Department of Pharmacology, Carver College of Medicine/University of Iowa, Iowa, IA 52242, USA Cell 5 National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China & 6 Beijing Institute for Brain Disorders, Beijing 100069, China & Correspondence: [email protected] (X. Li), [email protected] (W. Zhang) Received September 1, 2014 Accepted September 25, 2014 Protein ABSTRACT neutrophil counts in inflammatory skin caused by S. aureus. Mechanistically we found that CD177 deletion in Neutrophils play an essential role in the innate immune mouse neutrophils has no significant impact in CXCL1/ response to infection. Neutrophils migrate from the KC- or fMLP-induced migration, but led to significant cell vasculature into the tissue in response to infection. death. Herein we established a novel genetic mouse Recently, a neutrophil cell surface receptor, CD177, was model to study the role of CD177 and found that CD177 shown to help mediate neutrophil migration across the plays an important role in neutrophils.
    [Show full text]
  • Chapter 18 *Lecture Powerpoint the Circulatory System: Blood
    Chapter 18 *Lecture PowerPoint The Circulatory System: Blood *See separate FlexArt PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Introduction • Many myths about blood – Mysterious ―vital force‖ – Drained ―bad-blood‖ for medical reasons – Hereditary traits were once thought to be transmitted through blood • Blood cells were seen with the first microscopes • Hematology—the study of blood • Recent developments in this field help save lives 18-2 Introduction • Expected Learning Outcomes – Describe the functions and major components of the circulatory system. – Describe the components and physical properties of blood. – Describe the composition of blood plasma. – Explain the significance of blood viscosity and osmolarity. – Describe in general terms how blood is produced. 18-3 Functions of the Circulatory System • Circulatory system consists of the heart, blood vessels, and blood • Cardiovascular system refers only to the heart and blood vessels • Hematology—the study of blood • Functions of circulatory system – Transport • O2, CO2, nutrients, wastes, hormones, and stem cells – Protection • Inflammation, limit spread of infection, destroy microorganisms and cancer cells, neutralize toxins, and initiate clotting – Regulation • Fluid balance, stabilizes pH of ECF, and temperature control 18-4 Components and General Properties of Blood • Adults have 4 to 6 L of blood • A liquid connective tissue consisting of
    [Show full text]
  • AML Serum Mir-150 Mir-155 Mir-1246 Prog
    Supplementary Table S1. Summary of current studies on EVs as biomarkers Disease Source Cargo Role Reference AML serum TGF-β1, CD34, Prognostic [21] CD33, CD117 AML serum miR-150 Prognostic [23] miR-155 miR-1246 AML serum miR-125b Prognostic [24] AML serum miR-10b Prognostic [25] CLL serum CD19, CD37 Prognostic [27] CLL plasma S100-A9 protein Prognostic [29] CLL plasma CD52 Prognostic [30] CLL plasma miR-150, miR-155, Diagnostic [31] miR-223, miR-29 CD37, CD9, CD63 CLL plasma mc-COX2 Prognostic [33] MF plasma CD61, CD62P Prognostic [34] MM serum CD38, CD138, Prognostic [37] CD44, CD147 MM serum let-7b and miR-18a Prognostic [40] nHL /HL plasma CD20/CD30 Diagnostic/Prognostic [20] Lymphoma plasma CD20 Prognostic [43] HL plasma miR-23p Diagnostic [44] miR-127-3p miR-21-5p miR-155-5p let-7a-5p Lymphoma plasma BCL-6 Prognostic [45] c-myc 1 Supplementary Table S2. Summary of current studies on EVs: re-education of the bone marrow niche Disease EV Target Cargo Functional effects Reference origin/Source AML AML cells MSC/stromal / Downregulating of KITL, [52] cells CXCL12, IGF1; Reducing support to normal hemopoiesis AML AML cells Stromal cells miR-155 Reducing secretion of [54] miR-375 cytokines and growth factor; miR-150 Affecting retention and differentiation of HSC in the bone marrow AML/MDS AML/MDS cells MSC miR-7977 Reducing the hemopoiesis [55] supportive capacity CLL CLL cells MSC miR-202-3p Promoting migration, [32] survival and proliferation CLL Plasma Stromal cells / Production of VEGF, [26] promoting survival of B cells CLL CLL cells
    [Show full text]
  • ORIGINAL ARTICLE Flow Cytometric Protein Expression Profiling As a Systematic Approach for Developing Disease-Specific Assays
    Leukemia (2006) 20, 2102–2110 & 2006 Nature Publishing Group All rights reserved 0887-6924/06 $30.00 www.nature.com/leu ORIGINAL ARTICLE Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens AC Rawstron, R de Tute, AS Jack and P Hillmen Haematological Malignancy Diagnostic Service (HMDS), Leeds Teaching Hospitals, Leeds, UK Depletion of disease below the levels detected by sensitive sustained remissions only occur in patients achieving an MRD- minimal residual disease (MRD) assays is associated with negative complete response.12 Therefore MRD is increasingly prolonged survival in chronic lymphocytic leukaemia (CLL). being used as an end point for therapeutic trials, and several Flow cytometric MRD assays are now sufficiently sensitive and rapid to guide the duration of therapy in CLL, but generally rely studies are now using the assessment of MRD to define the on assessment of CD20 expression, which cannot be accurately duration of therapy. measured during and after therapeutic approaches containing Approaches using allele-specific oligonucleotide polymerase rituximab. The aim of this study was to use analytical software chain reaction (ASO-PCR) to the immunoglobulin gene of the developed for microarray analysis to provide a systematic B-CLL cell are generally accepted to show the highest sensitivity approach for MRD flow assay development. Samples from CLL for MRD detection. However, more recent four-colour ap- patients (n ¼ 49), normal controls (n ¼ 21) and other B-lympho- proaches show sensitivities nearing that of ASO-PCR6,11,13 with proliferative disorders (n ¼ 12) were assessed with a panel of 66 antibodies.
    [Show full text]
  • Immunocytochemical Analysis of Human Synovial Lining Cells: Phenotypic Relation to Other Marrow Ann Rheum Dis: First Published As 10.1136/Ard.50.5.311 on 1 May 1991
    Annals ofthe Rheumatic Diseases 1991; 50: 311-315 31 Immunocytochemical analysis of human synovial lining cells: phenotypic relation to other marrow Ann Rheum Dis: first published as 10.1136/ard.50.5.311 on 1 May 1991. Downloaded from derived cells N A Athanasou, J Quinn Abstract system,20 21 synovial lining cell specific The antigenic phenotype of human synovial progenitors are produced in the marrow by a lining cells in normal and hyperplastic synovial lining cell lineage that diverges at some synovium intima was determined with a panel early stage from that of monocytes and tissue of monoclonal antibodies directed against macrophages. a large number of well defined myeloid To investigate the origin and development of (macrophage/granulocyte associated) antigens. synovial lining cells further we sought to define Synovial lining cells express numerous macro- the antigenic phenotype of human synovial phage associated antigens, including CD11b lining cells and subintimal macrophages in the (CR3), CD13, CD14, CD16 (FcRIII), CD18, synovial membrane. We used a large number of CD32 (FcRII), CD45 (leucocyte common monoclonal antibodies directed against defined antigen), CD54 (ICAM-1), CD64 (FcRI), myeloid (granulocyte/macrophage associated) CD68, and CD71 (transferrin receptor). antigens for the immunohistochemical staining Few synovial lining cells expressed CD11a of human synovial lining cells and subintimal (LFA-1) and CD11c (p150,95). Subintimal macrophages in the synovial membrane. The macrophages expressed all the macrophage pattern of antigen expression by these cells not associated antigens which were present on only has implications for synovial lining cell synovial lining cells and, in addition, expressed origin and development but also for function CD15a, CD25 (interleukin-2 receptor), CD34, and interaction of these cells with other inflam- and CD35 (C3b receptor), none of which was matory cells.
    [Show full text]
  • CD48 Is Critically Involved in Allergic Eosinophilic Airway Inflammation
    CD48 Is Critically Involved in Allergic Eosinophilic Airway Inflammation Ariel Munitz,1 Ido Bachelet,1 Fred D. Finkelman,2 Marc E. Rothenberg,3 and Francesca Levi-Schaffer1,4 1Department of Pharmacology, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; 2Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; 3Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio; and 4David R. Bloom Center for Pharmacology, Hebrew University of Jerusalem, Jerusalem, Israel Rationale: Despite ongoing research, the molecular mechanisms con- trolling asthma are still elusive. CD48 is a glycosylphosphatidylinositol- AT A GLANCE COMMENTARY anchored protein involved in lymphocyte adhesion, activation, and costimulation. Although CD48 is widely expressed on hematopoi- Scientific Knowledge on the Subject etic cells and commonly studied in the context of natural killer and CD48 is an activation molecule able to facilitate various cytotoxic T cell functions, its role in helper T cell type 2 settings cellular activities. Its role in asthma is unknown. has not been examined. Objectives: To evaluate the expression and function of CD48, CD2, and 2B4 in a murine model of allergic eosinophilic airway inflammation. What This Study Adds to the Field Methods: Allergic eosinophilic airway inflammation was induced by CD48 is upregulated in experimental asthma. Anti-CD48– ovalbumin (OVA)–alum sensitization and intranasal inoculation of based therapies may be useful for asthma and perhaps OVA or, alternatively, by repeated intranasal inoculation of Aspergil- various allergic diseases. lus fumigatus antigen in wild-type, STAT (signal transducer and acti- vator of transcription)-6–deficient, and IL-4/IL-13–deficient BALB/c mice.
    [Show full text]
  • Cd1a [O10] Concentrated and Prediluted Monoclonal Antibody 901-3158-061719
    CD1a [O10] Concentrated and Prediluted Monoclonal Antibody 901-3158-061719 Catalog Number: ACI 3158 A, B API 3158 AA VLTM 3158 G20 Description: 0.1, 0.5 mL conc. 6.0 mL, RTU 20 mL, RTU Dilution: 1:100 Ready-to-use Ready-to-use Diluent: Van Gogh Yellow N/A N/A Intended Use: Protocol Recommendations (VALENT® Automated Slide For In Vitro Diagnostic Use Staining Platform) Cont’d: CD1a [O10] is a mouse monoclonal antibody that is intended for Protein Block (Optional): Incubate for 10-20 minutes at RT with Val laboratory use in the qualitative identification of CD1a protein by Background Block. immunohistochemistry (IHC) in formalin-fixed paraffin-embedded Primary Antibody: Incubate for 30 minutes. (FFPE) human tissues. The clinical interpretation of any staining or its Secondary: Incubate for 10 minutes with Val Mouse Secondary. absence should be complemented by morphological studies using proper Linker: Incubate for 10 minutes with Val Universal Linker. controls and should be evaluated within the context of the patient’s Polymer: Incubate for 10 minutes with Val Universal Polymer. clinical history and other diagnostic tests by a qualified pathologist. Chromogen: Incubate for 5 minutes with Val DAB. Summary and Explanation: Counterstain: Counterstain for 5 minutes with Val Hematoxylin. CD1a is a protein of 43 to 49 kDa and is expressed on dendritic cells and cortical thymocytes (1,2). CD1a [O10] staining has been shown to be Protocol Recommendations (intelliPATH FLX® and manual use): useful in the differentiation of Langerhans cells from interdigitating cells. Peroxide Block: Block for 5 minutes with Peroxidazed 1. It has also proved useful for phenotyping Langerhans cell histiocytosis Pretreatment: Perform heat retrieval using Diva or Reveal Decloaker.
    [Show full text]
  • Single-Cell RNA Sequencing Demonstrates the Molecular and Cellular Reprogramming of Metastatic Lung Adenocarcinoma
    ARTICLE https://doi.org/10.1038/s41467-020-16164-1 OPEN Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma Nayoung Kim 1,2,3,13, Hong Kwan Kim4,13, Kyungjong Lee 5,13, Yourae Hong 1,6, Jong Ho Cho4, Jung Won Choi7, Jung-Il Lee7, Yeon-Lim Suh8,BoMiKu9, Hye Hyeon Eum 1,2,3, Soyean Choi 1, Yoon-La Choi6,10,11, Je-Gun Joung1, Woong-Yang Park 1,2,6, Hyun Ae Jung12, Jong-Mu Sun12, Se-Hoon Lee12, ✉ ✉ Jin Seok Ahn12, Keunchil Park12, Myung-Ju Ahn 12 & Hae-Ock Lee 1,2,3,6 1234567890():,; Advanced metastatic cancer poses utmost clinical challenges and may present molecular and cellular features distinct from an early-stage cancer. Herein, we present single-cell tran- scriptome profiling of metastatic lung adenocarcinoma, the most prevalent histological lung cancer type diagnosed at stage IV in over 40% of all cases. From 208,506 cells populating the normal tissues or early to metastatic stage cancer in 44 patients, we identify a cancer cell subtype deviating from the normal differentiation trajectory and dominating the metastatic stage. In all stages, the stromal and immune cell dynamics reveal ontological and functional changes that create a pro-tumoral and immunosuppressive microenvironment. Normal resident myeloid cell populations are gradually replaced with monocyte-derived macrophages and dendritic cells, along with T-cell exhaustion. This extensive single-cell analysis enhances our understanding of molecular and cellular dynamics in metastatic lung cancer and reveals potential diagnostic and therapeutic targets in cancer-microenvironment interactions. 1 Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea.
    [Show full text]